Bristol-Myers Squibb has teamed with Infinity Pharmaceuticals to add another study to its burgeoning roster of combination trials featuring PD-1 drug Opdivo.

An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…

An IPO for Ra Pharmaceuticals has priced raising $92 million, while another for Myovant Sciences has commitments from Pfizer and BB Biotech.

A St. Louis, MO-based preclinical startup has nabbed a GSK partnership. The pair will focus on antibiotic-sparing drugs to treat and prevent urinary tract…

NantVentures has made an investment in microcap Australian biotech Benitec Biopharma.

NeuroVive Pharmaceutical has resolved its standoff with Arbutus Biopharma and regained control of a hepatitis B candidate.

Novartis teed up its second discovery deal of the day with an investment and partnership with Perlara PBC to discover and develop treatments for lysosomal…

Novartis has picked microcap Cerulean Pharma for a discovery and development deal, just as Aspire Capital offers to invest $20 million.

Partnering